NinePointTwo Capital LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 236 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
NinePointTwo Capital LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$120
-16.1%
17,1740.0%0.05%
-14.8%
Q1 2023$143
-27.4%
17,1740.0%0.05%
-34.1%
Q4 2022$19717,1740.08%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
RP Management, LLC 3,846,154$62,538,00025.44%
ORACLE INVESTMENT MANAGEMENT INC 1,720,733$27,979,0005.53%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 57,000$19,282,0004.35%
MPM BioImpact LLC 639,089$10,392,0002.79%
Parkman Healthcare Partners LLC 476,978$7,756,0002.27%
Sarissa Capital Management LP 1,390,790$22,614,0002.14%
Ghost Tree Capital, LLC 350,000$5,691,0001.24%
Lisanti Capital Growth, LLC 662,644$10,775,0001.21%
Baker Brothers Advisors 12,710,818$206,678,0001.19%
Tamarack Advisers, LP 125,000$2,033,0000.96%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders